Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.98 USD | -1.48% | +1.58% | +55.27% |
Financials (USD)
Sales 2024 * | 1B | Sales 2025 * | 1.17B | Capitalization | 728M |
---|---|---|---|---|---|
Net income 2024 * | 13M | Net income 2025 * | 29M | EV / Sales 2024 * | 0.96 x |
Net Debt 2024 * | 233M | Net Debt 2025 * | 463M | EV / Sales 2025 * | 1.02 x |
P/E ratio 2024 * |
54.5
x | P/E ratio 2025 * |
25.1
x | Employees | 1,920 |
Yield 2024 * |
2.67% | Yield 2025 * |
2.63% | Free-Float | 49.9% |
Latest transcript on Phibro Animal Health Corporation
1 day | -1.48% | ||
1 week | +1.58% | ||
Current month | +7.66% | ||
1 month | +38.41% | ||
3 months | +48.96% | ||
6 months | +70.75% | ||
Current year | +55.27% |
Managers | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
Glenn David
DFI | Director of Finance/CFO | 52 | Feb. 08 |
Larry Miller
COO | Chief Operating Officer | 60 | 08-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jack Bendheim
CEO | Chief Executive Officer | 77 | 68-12-31 |
E. Corcoran
BRD | Director/Board Member | 77 | 08-04-30 |
Carol Wrenn
BRD | Director/Board Member | 63 | 10-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.33% | 25 M€ | -1.18% | - | |
0.32% | 28 M€ | -0.39% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 17.98 | -1.48% | 101,517 |
24-05-15 | 18.25 | +0.22% | 148,299 |
24-05-14 | 18.21 | +0.55% | 178,907 |
24-05-13 | 18.11 | +3.19% | 161,917 |
24-05-10 | 17.55 | -0.85% | 127,608 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+55.27% | 728M | |
-11.98% | 79.26B | |
+25.75% | 3.74B | |
0.00% | 3.27B | |
+17.06% | 1.69B | |
-6.22% | 1.56B | |
-23.36% | 1.29B | |
-3.03% | 1.28B | |
-12.76% | 1.14B | |
+0.79% | 1.06B |
- Stock Market
- Equities
- PAHC Stock